Pharmaceuticals News and Research

RSS

Roche to transfer technology for Saquinavir to three generic drug companies in Africa

Switzerland-based pharmaceutical company Roche on Friday said it will provide three generic drug companies in sub-Saharan Africa assistance in producing the protease inhibitor saquinavir under its Technology Transfer Initiative, Reuters South Africa reports (Reuters South Africa, 9/22).

26 Sep 2006

In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer

Investigators developing an inhalable nanoparticle for treating lung cancer have shown that a surface molecule found on malignant lung cells can serve as an effective target for improving drug delivery.

25 Sep 2006

WHO establishes secretariat on public health, innovation, health research and intellectual property

The World Health Organization (WHO) has established a secretariat on Public Health, Innovation, Essential Health Research and Intellectual Property.

25 Sep 2006

Many Medicare beneficiaries lack coverage in prescription drug benefit 'doughnut hole'

Eighty-eight percent of Medicare beneficiaries enrolled in stand-alone drug plans under the Medicare prescription drug benefit are in plans that do not provide coverage during the so-called "doughnut hole," according to a report released on Thursday by Democrats on the House Ways and Means Committee, the AP/Boston Globe reports.

22 Sep 2006

Prices on medications most commonly used by older people rose 4.3% in first half of 2006

Manufacturer prices for the brand-name drugs most commonly used by individuals ages 50 and older increased by an average of 6.3% during the 12-month period ending in June, according to an AARP survey released on Tuesday, the Newark Star-Ledger reports.

22 Sep 2006

Inclusion of prescription drug reimportation provision in delaying action on homeland security appropriations

Provisions that would permit U.S. residents to purchase lower-cost prescription drugs from abroad have become a "major sticking point" to settling negotiations on the House and Senate fiscal year 2007 Homeland Security appropriations bills, CongressDaily reports (CongressDaily, 9/19).

22 Sep 2006

Combating generics: pharmaceutical brand defense for 2007

Court cases regarding patent infringement effectively slow generics in coming to market, however US lawmakers and FDA continue to make it easier for generic drugs to gain approval (Cutting Edge Information).

21 Sep 2006

Computer model reveals a central "road" in the human stomach

A computer model or "virtual stomach" revealed a central "road" in the human stomach, dubbed the Magenstrasse, that could explain why pharmaceuticals sometimes have a large variability in drug activation times, according to a team creating computer simulations of stomach contractions.

20 Sep 2006

Use of unapproved drugs in the U.S.

USA Today on Monday looked at the use of unapproved drugs in the U.S., including some that are used to treat menopause symptoms (Rubin, USA Today, 9/18).

20 Sep 2006

Five countries to tax airline travel to raise money for HIV/AIDS

Brazil, Chile, France, Norway and the United Kingdom on Tuesday at the 61st session of the U.N. General Assembly are expected to announce a plan to impose an airline ticket tax to fund an international drug purchase facility and HIV/AIDS, tuberculosis and malaria treatment and prevention programs, a French official said Monday, the New York Times reports.

20 Sep 2006

Medical Centers should follow Stanford's lead in banning gifts from drug companies

Stanford University Medical Center's decision to prohibit physicians from accepting any gifts from pharmaceutical sales representatives is "an austere measure that other medical centers should follow," a Los Angeles Times editorial states.

20 Sep 2006

Thousands of prescription drug products sold in the U.S. not approved by FDA

Drugs that have not been approved by FDA make up nearly 2% of prescription drugs on the market, and some of them "might not only be ineffective but also might actually be harmful," USA Today reports.

20 Sep 2006

House subcomittee hearing focuses on disciplinary measures for NIH scientists' ethnics violations

NIH officials have not adequately disciplined agency scientists found to have violated ethics rules, members of the House Energy and Commerce Subcommittee on Oversight and Investigations said at a hearing last Wednesday.

18 Sep 2006

Oregon Prescription Drug Program would expand coverage to all uninsured residents

An initiative that will appear on the November ballot in Oregon would expand a state prescription drug program to cover all residents without drug coverage, the Oregonian reports.

18 Sep 2006

GSK to supply antiretroviral drugs to Russia at discounted price

GlaxoSmithKline has announced it would supply 90,000 packs of its antiretroviral drugs Combivir, Epivir and Ziagen to Russia at discounted prices by the end of 2006, the AFP/Yahoo! U.K and Ireland reports (AFP/Yahoo! U.K and Ireland, 9/15).

18 Sep 2006

More physicians now visit web sites to find information on brand-name prescription drugs

An increased number of physicians visited Web sites that promote brand-name prescription drugs during the first six months of 2006 to seek information about dosages and side effects, according to a recent Manhattan Research study, the Newark Star-Ledger reports.

18 Sep 2006

Extremely virulent, drug resistant strain of TB running wild in South Africa

It was 18 months ago when doctors in South Africa who were treating HIV/AIDS patients first raised the alarm that an untreatable form of tuberculosis (TB) was circulating.

18 Sep 2006

Most Federal scientists accused of conflicts of interest avoid criminal investigations

Only two of the 44 NIH scientists found to have violated ethics rules on outside consulting agreements with health care companies face investigations for possible criminal activity, and they remain employed by the federal government, the AP/Arizona Daily Star reports (Beamish, AP/Arizona Daily Star, 9/13).

14 Sep 2006

Department of Justice joins Whistleblower lawsuit alleging overcharging by drug company Dey

The Department of Justice on Monday joined a whistleblower lawsuit filed against California-based Dey, a generic medication division of Germany-based Merck KGaA, over allegations that the company inflated prices reported to federal health insurance programs, the Boston Globe reports.

13 Sep 2006

High copayments for 'specialty pharmacy' medications has little effect on use

Higher copayments have a small effect on usage of "specialty pharmacy" medications, which can cost as much as $10,000 monthly, according to a study published Tuesday in the journal Health Affairs, the Pittsburgh Post-Gazette reports.

13 Sep 2006

Pharmaceuticals News and Research

Roche to transfer technology for Saquinavir to three generic drug companies in Africa

In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer

WHO establishes secretariat on public health, innovation, health research and intellectual property

Many Medicare beneficiaries lack coverage in prescription drug benefit 'doughnut hole'

Prices on medications most commonly used by older people rose 4.3% in first half of 2006

Inclusion of prescription drug reimportation provision in delaying action on homeland security appropriations

Combating generics: pharmaceutical brand defense for 2007

Computer model reveals a central "road" in the human stomach

Use of unapproved drugs in the U.S.

Five countries to tax airline travel to raise money for HIV/AIDS

Medical Centers should follow Stanford's lead in banning gifts from drug companies

Thousands of prescription drug products sold in the U.S. not approved by FDA

House subcomittee hearing focuses on disciplinary measures for NIH scientists' ethnics violations

Oregon Prescription Drug Program would expand coverage to all uninsured residents

GSK to supply antiretroviral drugs to Russia at discounted price

More physicians now visit web sites to find information on brand-name prescription drugs

Extremely virulent, drug resistant strain of TB running wild in South Africa

Most Federal scientists accused of conflicts of interest avoid criminal investigations

Department of Justice joins Whistleblower lawsuit alleging overcharging by drug company Dey

High copayments for 'specialty pharmacy' medications has little effect on use

Pittcon Highlights: Pharmaceutical & Biologic eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring